Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine-Reference-Cited by-同舟云学术

Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine

Published:2018-02-03 Issue:3 Volume:67 Page:411-419
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Glidden David V¹,Mulligan Kathleen¹,McMahan Vanessa²,Anderson Peter L³,Guanira Juan⁴,Chariyalertsak Suwat⁵,Buchbinder Susan P¹⁶,Bekker Linda-Gail¹⁷,Schechter Mauro⁸,Grinsztejn Beatriz⁹,Grant Robert M¹⁰¹¹

Affiliation:

1. University of California, San Francisco

2. University of Washington, Seattle

3. University of Colorado, Denver, Aurora

4. Investigaciones Médicas en Salud, Lima, Peru

5. Research Institute for Health Sciences, Chiang Mai University, Thailand

6. Bridge HIV, San Francisco Department of Public Health, California

7. Desmond Tutu HIV Foundation, Cape Town, South Africa

8. Projeto Praça Onze, Hospital Escola São Francisco de Assis and Universidade Federal do Rio de Janeiro

9. Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil

10. Gladstone Institute of Virology, California

11. San Francisco AIDS Foundation, California

Funder

National Institute of Allergy and Infectious Diseases

National Academy for Advancing Translational Science

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/67/3/411/25156350/ciy083.pdf

Reference34 articles.

1. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

2. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

3. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana;Thigpen;N Engl J Med,2012

4. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial;Choopanya;Lancet,2013

5. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection;Molina;N Engl J Med,2015

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weight Gain and Antiretroviral Therapy;Infectious Disease Clinics of North America;2024-09

2. HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial;The Lancet HIV;2024-08

3. Choice of antiretroviral therapy has low impact on weight gain;AIDS;2024-05-31

4. Antiretrovirals and Weight Change: Weighing the Evidence;Clinical Infectious Diseases;2024-04-12

5. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials;The Lancet HIV;2024-02